These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11936970)

  • 1. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides.
    Bertoni C; Rando TA
    Hum Gene Ther; 2002 Apr; 13(6):707-18. PubMed ID: 11936970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides.
    Rando TA; Disatnik MH; Zhou LZ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5363-8. PubMed ID: 10805797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide-mediated gene therapy for muscular dystrophies.
    Rando TA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S55-60. PubMed ID: 12206797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping.
    Bertoni C; Lau C; Rando TA
    Hum Mol Genet; 2003 May; 12(10):1087-99. PubMed ID: 12719373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs.
    Kayali R; Bury F; Ballard M; Bertoni C
    Hum Mol Genet; 2010 Aug; 19(16):3266-81. PubMed ID: 20542988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.
    Nik-Ahd F; Bertoni C
    Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strand bias in oligonucleotide-mediated dystrophin gene editing.
    Bertoni C; Morris GE; Rando TA
    Hum Mol Genet; 2005 Jan; 14(2):221-33. PubMed ID: 15563511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
    Mueller GM; O'Day T; Watchko JF; Ontell M
    Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci.
    Kapsa RM; Wong SH; Bertoncello I; Quigley AF; Williams B; Sells K; Marotta R; Kita M; Simmons P; Byrne E; Kornberg AJ
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S61-6. PubMed ID: 12206798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
    Vilquin JT; Kennel PF; Paturneau-Jouas M; Chapdelaine P; Boissel N; Delaère P; Tremblay JP; Scherman D; Fiszman MY; Schwartz K
    Gene Ther; 2001 Jul; 8(14):1097-107. PubMed ID: 11526457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement.
    Kapsa R; Quigley A; Lynch GS; Steeper K; Kornberg AJ; Gregorevic P; Austin L; Byrne E
    Hum Gene Ther; 2001 Apr; 12(6):629-42. PubMed ID: 11426463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
    Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
    Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
    Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
    Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
    Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.